Diabetes News and Research

Latest Diabetes News and Research

Digital platform supports personalized diet goals in primary care for diabetes

A recent study in the Journal of Nutrition Education and Behavior, published by Elsevier, evaluated the feasibility of Nutri, a user-centered digital platform designed to support personalized, evidence-based diet goal setting during routine primary care visits for patients with type 2 diabetes.

9 Jul 2025

Experimental treatment reverses paralysis in child with rare mitochondrial disease

The value of a recent biochemical discovery can be seen in the case of an 8-year-old boy. In August 2023 he was able to play typical sports, but by November he needed a wheelchair because of a rare disease that caused worsening paralysis.

9 Jul 2025

MIT develops implantable device to automatically release emergency glucagon

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is injecting a hormone called glucagon.

9 Jul 2025

Innovative genome editing approach could be the key to lifelong effective weight management

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss drugs, doing away with injections in favor of a one-time treatment.

9 Jul 2025

New Scientific Statement outlines future research directions for type 1 diabetes

A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes (T1D) that should help with the development of new and improved treatment options.

9 Jul 2025

Study finds no metabolic danger from ultra-processed foods

Research shows ultra-processed foods contribute to poor diet quality without a significant association to metabolic syndrome among European children and adults.

9 Jul 2025

New study identifies factors linked to successful weight loss using GLP-1RAs

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss after taking prescription drugs called glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide (sold under the brand names Ozempic and Wegovy).

9 Jul 2025

Redefining Alzheimer’s development by mapping disease sequences

UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.

9 Jul 2025

Many Americans misunderstand the health impact of processed foods

Thirty-nine percent of respondents to an online poll incorrectly said all processed foods are unhealthy, according to new research by the Physicians Committee for Responsible Medicine published today, July 8, 2025, in JAMA Network Open.

9 Jul 2025

More fiber, fewer health risks: evidence for this easy diet fix

This study reveals that adequate dietary fiber intake is crucial for lowering obesity risk and mortality, supporting its role in effective weight management.

9 Jul 2025

Why vitamin B6 could raise the risk of hypoglycemia for people with diabetes

A large-scale Mendelian randomization study found no genetic evidence that vitamins A, C, or D reduce the risk of major diabetic complications. However, higher genetically predicted vitamin B6 levels were strongly associated with increased risk of diabetic hypoglycemia, warranting caution with supplementation.

8 Jul 2025

Can dietary copper help protect against dementia and memory loss?

Higher dietary copper intake was linked to better cognitive performance in older US adults, with benefits plateauing above a certain threshold. The effect was especially notable in stroke survivors, but further research is needed to confirm causality.

8 Jul 2025

UCLA researchers discover new way to prevent immunotherapy-induced type 1 diabetes

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, a rare but life-threatening side effect of cancer immunotherapy, using an existing class of autoimmune drugs.

8 Jul 2025

Waist-to-hip and waist-to-height ratios predict physical performance in adults

A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on May 30, 2025, titled "Impact of waist-to-hip and waist-to-height ratios on physical performance: insights from the Longevity Check-up 8+ project."

8 Jul 2025

Salivary enzyme levels rise with gene variation in diabetics

This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for glucose homeostasis in diabetes.

8 Jul 2025

KAIST scientists develop tool to fight drug resistance in cancer

One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on identifying new drug targets to eliminate these resistant cells, but such approaches can often lead to even stronger resistance.

8 Jul 2025

New gene editing approach targets mutation behind common genetic heart disease

Fourteen million people worldwide suffer from enlarged hearts, or hypertrophic cardiomyopathy (HCM), a genetic disease that thickens the heart's walls, making it harder for the organ to pump blood - but many of them don't know it.

8 Jul 2025

New study finds UK mums-to-be miss out on key nutrients

A new British Nutrition Foundation review finds that most UK women of reproductive age fall short of key nutrients before and during pregnancy, with teens and low-income groups most affected. The paper urges targeted, consistent guidance and greater support for healthy weight, supplementation, and plant-based diets.

7 Jul 2025

Tirzepatide tops the charts for blood sugar and weight loss in type 2 diabetes

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with type 2 diabetes. Tirzepatide demonstrated the greatest efficacy for glucose control and weight loss, while liraglutide offered the lowest hypoglycemia risk.

7 Jul 2025

Cysteine plays key role in weight loss and fat metabolism

Consuming fewer calories is largely accepted as a way to improve health and lose weight, but a recently published study in Nature Metabolism points to a specific sulfur-containing amino acid cysteine as a key component in weight loss.

7 Jul 2025